Latest Stories
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Pharmaceutical company AbbVie (NYSE:ABBV) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.6% year on year to $15.1 billion. Its non-GAAP profit of $2.16 per share was 4.3% below analysts’ consensus estimates.
RBC Bearings (RBC) Shares Skyrocket, What You Need To Know
Shares of bearings manufacturer RBC Bearings (NYSE:RBC) jumped 10.6% in the afternoon session after the company reported strong fourth-quarter results, which revealed improved sales trends, with management anticipating incremental volume recovery in the aerospace segment and a return to growth in the industrial business. It was also encouraging to see RBC Bearings beat analysts' EBITDA and EPS estimates. Overall, this quarter had some key positives.
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year revenue guidance of $2.83 billion at the midpoint came in 1.3% below analysts’ estimates. Its non-GAAP profit of $1.42 per share was 3.1% above analysts’ consensus estimates.